IGV-001 extended median overall survival to 20.3 months, 6.3 months longer than placebo, in newly diagnosed glioblastoma patients. The phase 2b trial showed a favorable safety profile, consistent with ...
In trading on Tuesday, shares of the iShares Expanded Tech-Software Sector ETF (Symbol: IGV) entered into oversold territory, changing hands as low as $96.045 per share. We define oversold territory ...
When discussing progress made in AI technology so far, a common phrase stated one way or another is “We’re in the early innings." Baseball references aside, it is largely thought that the buildup of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results